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Motor Neuronopathy associated with Adenocarcinoma of Esophagus
B. A. Khealani, R. Qureshi, M. Wasay
Section of Neurology, Department of Medicine, The Aga Khan University Hospital, Karachi.
Neurologic paraneoplastic syndromes (NPS) are
remote neurologic effects, except metastasis, of systemic
cancers. These are a rare group of disorders, commonly
associated with small cell lung carcinoma (SCLC).1 Various
NPS have been described, including motor neuronopathy.
The motor neuronopathy has commonly been described
with small cell carcinoma of lung, breast cancer and
lymphoproliferative disorders.2,3 We report a case of motor
neuronopathy in association with large cell adenocarcinoma
of esophagus. To our knowledge this is the first reported
case of motor neuronopathy associated with
adenocarcinoma of the esophagus.
Case Report
A 57-year old man, smoker, presented with a 2-
months history of progressive walking difficulty. He was
emaciated and his neurological examination was significant
for absent gag reflex, mild proximal limb weakness (power
of 4/5 on MRC scale), impaired proprioception and ataxic
gait. Chest, abdominal and cardiovascular examination was
normal. There was no lymphadenopathy. His complete
blood counts, serum electrolytes, liver function tests, CPK
were normal. Motor nerve conduction studies of right
median, ulnar, posterior tibial and peroneal nerves revealed
mildly slow conduction velocities. However, there was no
conduction block. Sensory nerve conduction studies of
bilateral sural, right median and right ulnar nerves were
normal. The EMG findings were suggestive of anterior horn
cell disorder (motor neuronopathy). He developed
complaints of dysphagia. An upper GI endoscopy revealed
a fungating and ulcerated growth at distal esophagus,
confirmed on histopathology to be large cell
adenocarcinoma. Later patient developed mental status
changes and blindness. MRI brain showed multiple
hemorrhagic metastasis to bone (sternum). An esophageal
stent was placed and patient was managed conservatively.
Later he developed recurrent pneumonia and died two
months after the initial presentation.
Discussion
Neurologic paraneoplastic syndrome was first
described by Oppenhiem in 1888.1 The exact incidence of
neurologic paraneoplastic syndrome is not known, however
incidence in patients with SCLC, the most commonly
associated tumor with the syndromes, is less than 3%.1 The
mechanism of development of neurologic paraneoplastic
syndrome is not fully understood, however, there is
evidence that this is an autoimmune phenomenon.4 In
addition to autoimmunity, role of opportunistic viral
infections has been proposed as underlying mechanism for
motor neuropathy.1 The paraneoplastic syndrome can effect
any part of nervous system including spinal cord/anterior
horn cells. The paraneoplastic motor neuron disease (motor
neuronopathy) has commonly been reported in association
with SCLC, breast cancer and lymphoproliferative
disorders.2,3 To our knowledge there are only two reports of
motor neuronopathy in association with esophageal
cancers5,6 and none of these was adenocarcinoma. We
reported motor neuronopathy in association of large cell
esophageal adenocarcinoma. EMG findings of our patient
are suggestive of anterior horn cell disorder/motor
neuronopathy. Our patient did have evidence of
reinnervation in three body regions and denervation in only
two regions. Furthermore, normal sensory nerve conduction
studies, normal CMAP amplitudes, normal distal motor
latencies and widespread reinnervating motor unit
potentials and patchy active denervation suggest anterior
horn cell disorder. Mildly slow conduction velocities could
also be seen in axonal neuropathy and multifocal motor
neuropathy with conduction block (MMNCB) but
preserved compound muscle action potential and absence of
conduction block  makes  these  diagnoses  unlikely  in our 
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patient. The ataxic gait in our patient could also be a feature
of paraneoplastic cerebellar degeneration (PCD). The
paraneoplastic motor neuropathy has been described to be
part of paraneoplastic encephalomyelopathy/subacute
sensory neuronopathy (PEM/SSN) in about 25% of cases.7
We conclude that our patient has motor neuronopathy in
setting of esophageal adenocarcinoma, which has not been
described previously. This can emphasizes the established
fact that paraneoplastic syndrome can be initial
manifestation of underlying malignancy. This also
highlights the importance of electrodiagnostic studies in
appropriate settings. We believe that any cancer patient with
neurologic symptoms, suggesting peripheral nervous
system involvement should undergo nerve conduction and
electromyography. Paraneoplastic syndrome can be
associated with adenocrcinoma of esophagus.
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